Research theme for competitive and other funds (6)：
2017 - 2020 低分子量G蛋白質を標的とした新規自閉症治療薬の探索
2017 - 2020 注意欠如多動性障害(ADHD)における細胞接着分子Arcadlinの関与
2012 - 2016 Regulatory mechanism of dendritic spine morphology by microRNA
2012 - 2016 The role of a candidate gene in the etiology of autism spectrum disorder
2008 - 2010 The molecular mechanism and behavioral abnormality in autism models
2005 - 2006 自閉症モデル動物におけるシナプス形成異常の分子メカニズムの解明
Show all
Papers (34)：
Shimada T, Yasuda S, Sugiura H, Yamagata K. Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions. International journal of molecular sciences. 2019. 20. 17
S. Yasuda, H. Sugiura, S. Katsurabayashi, K. Iwasaki, O. Hino, K. Yamagata. A novel mechanism for dendritic spine abnormality in tuberous sclerosis. JOURNAL OF NEUROCHEMISTRY. 2012. 123. 71-71
Mek3 In Encyclopedia of Signaling Molecules
2012 ISBN:9781441904607
Activity-dependent spine remodeling and brain disorders. In Dendritic Spines: Biochemistry, Modeling and Properties
Nova Science Publishers 2009 ISBN:1607414600
Mek3, In Encyclopedia of Signaling Molecules, 2nd Edition
Springer ISBN:9781441904607
Lectures and oral presentations (3)：
未病対策の一環としての認知症医療の現状と課題
(地域医療連携研修会 2019)
Protocadherin Arcadlin Regulates Seizure-induced Synaptic Loss by Activating p38 MAP Kinase Signaling
(3'rd BIT Peptide and Protein Conference (Pepcon)-2010 2010)
